IkB/BLyS (Clayton)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIkB/BLyS (Clayton)
Drug Alias NameI kappa B/B cell-activating factor receptor modulator(Clayton)I kappa B/BAFFR fusion (Clayton)I kappa B/B-cell lymphocyte stimualtor (Clayton)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionB-cell activating factor receptor modulators
TargetsB-cell activating factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClayton Foundation For Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClayton Biotechnologies IncClayton Foundation For Research
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A